Clin2
NCT06512441Possibly a fitRecruiting

Vitamin B6 for inflammatory bowel disease

Inflammatory Bowel Diseases

Treatments studied

Part of Digestive system clinical trials.

This study tests whether vitamin B6 can help treat inflammatory bowel disease (IBD). It may offer a simple, low-cost option to support your current treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
220 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must have a confirmed diagnosis of Crohn's disease or ulcerative colitis (types of IBD).
  • You cannot have taken vitamin B6 supplements in the last 3 months.
  • You cannot have nerve damage (peripheral neuropathy) or certain serious bowel complications like abscess or toxic megacolon.
  • You cannot have other major illnesses like cancer, severe heart or liver disease, or active infections.
  • You cannot be pregnant, breastfeeding, or planning to become pregnant within the next 6 months.
  • You must not be taking levodopa, phenobarbital, or phenytoin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06342011Recruiting
Anti-inflammatory diet for inflammatory bowel disease

This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.

Yiwu, Zhejiang
NCT07259603Not yet recruiting
Vitamin D deficiency and inflammatory bowel disease study

This trial looks at whether low vitamin D levels are linked to inflammatory bowel disease (Crohn's and ulcerative colitis). It may help understand the role of vitamin D in managing these conditions.

NCT07017959Not yet recruiting
Probiotic supplement for gut health in IBD

This study tests whether a daily supplement containing a special probiotic can help strengthen the gut lining and reduce inflammation in people with inflammatory bowel disease (IBD). If you have mild to moderate Crohn's or colitis, you may be able to join.

Tampa, Florida
NCT06995170Recruiting
Polyamines and IBD progression study

This study looks at how certain natural chemicals called polyamines relate to the activity of inflammatory bowel disease (IBD). It aims to understand if these chemicals can help predict disease progression.

Xi'an, Shaanxi
NCT06754891Recruiting· Phase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease

This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.

Bengbu, Anhui
NCT07047339Recruiting· Phase 2/Phase 3
Probiotic 6600 for colitis patients

This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.

Shanghai

Hear when a new Inflammatory Bowel Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.